Jindal Stainless Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 5, 2025, 10:42 pm

Quick Insight

Jindal Stainless Ltd's current market dynamics reveal a stock trading at a P/E ratio of 25.8, indicating investor confidence in future earnings growth. The company's robust Return on Equity (ROE) and Return on Capital Employed (ROCE) at 16.2% and 18.2% respectively underscore efficient capital allocation and profitability. With a healthy Operating Profit Margin (OPM) of 13%, Jindal Stainless demonstrates operational strength within the competitive steel industry. However, the firm's significant borrowings of ₹6,402Cr raise leverage concerns, though manageable with an Interest Coverage Ratio (ICR) of 17.31x. Overall, investors should monitor the company's debt levels closely to ensure sustainable growth and profitability in the long term.

Competitors of Jindal Stainless Ltd

All Competitor Stocks of Jindal Stainless Ltd

Quarterly Result

Last Updated: August 20, 2025, 8:35 am

Below is a detailed analysis of the quarterly data for Jindal Stainless Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 10,207.00 Cr.. The value appears strong and on an upward trend. It has increased from 10,198.00 Cr. (Mar 2025) to 10,207.00 Cr., marking an increase of 9.00 Cr..
• For Expenses, as of Jun 2025, the value is 8,911.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 9,165.00 Cr. (Mar 2025) to 8,911.00 Cr., marking a decrease of 254.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 1,296.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,033.00 Cr. (Mar 2025) to 1,296.00 Cr., marking an increase of 263.00 Cr..
• For OPM %, as of Jun 2025, the value is 13.00%. The value appears strong and on an upward trend. It has increased from 10.00% (Mar 2025) to 13.00%, marking an increase of 3.00%.
• For Other Income, as of Jun 2025, the value is 69.00 Cr.. The value appears to be declining and may need further review. It has decreased from 87.00 Cr. (Mar 2025) to 69.00 Cr., marking a decrease of 18.00 Cr..
• For Interest, as of Jun 2025, the value is 144.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 150.00 Cr. (Mar 2025) to 144.00 Cr., marking a decrease of 6.00 Cr..
• For Depreciation, as of Jun 2025, the value is 252.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 241.00 Cr. (Mar 2025) to 252.00 Cr., marking an increase of 11.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 969.00 Cr.. The value appears strong and on an upward trend. It has increased from 729.00 Cr. (Mar 2025) to 969.00 Cr., marking an increase of 240.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 19.00% (Mar 2025) to 26.00%, marking an increase of 7.00%.
• For Net Profit, as of Jun 2025, the value is 715.00 Cr.. The value appears strong and on an upward trend. It has increased from 590.00 Cr. (Mar 2025) to 715.00 Cr., marking an increase of 125.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 8.67. The value appears strong and on an upward trend. It has increased from 7.17 (Mar 2025) to 8.67, marking an increase of 1.50.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 6:13 am

Growth

Last Updated: September 5, 2025, 8:20 am

Balance Sheet

Last Updated: May 13, 2025, 3:16 pm

Below is a detailed analysis of the balance sheet data for Jindal Stainless Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 165.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 165.00 Cr..
• For Reserves, as of Mar 2025, the value is 16,523.00 Cr.. The value appears strong and on an upward trend. It has increased from 14,193.00 Cr. (Mar 2024) to 16,523.00 Cr., marking an increase of 2,330.00 Cr..
• For Borrowings, as of Mar 2025, the value is 6,402.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 6,052.00 Cr. (Mar 2024) to 6,402.00 Cr., marking an increase of 350.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 13,068.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 10,355.00 Cr. (Mar 2024) to 13,068.00 Cr., marking an increase of 2,713.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 36,158.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 30,765.00 Cr. (Mar 2024) to 36,158.00 Cr., marking an increase of 5,393.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 14,813.00 Cr.. The value appears strong and on an upward trend. It has increased from 13,254.00 Cr. (Mar 2024) to 14,813.00 Cr., marking an increase of 1,559.00 Cr..
• For CWIP, as of Mar 2025, the value is 1,770.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,112.00 Cr. (Mar 2024) to 1,770.00 Cr., marking an increase of 658.00 Cr..
• For Investments, as of Mar 2025, the value is 1,646.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,246.00 Cr. (Mar 2024) to 1,646.00 Cr., marking an increase of 400.00 Cr..
• For Other Assets, as of Mar 2025, the value is 17,929.00 Cr.. The value appears strong and on an upward trend. It has increased from 15,152.00 Cr. (Mar 2024) to 17,929.00 Cr., marking an increase of 2,777.00 Cr..
• For Total Assets, as of Mar 2025, the value is 36,158.00 Cr.. The value appears strong and on an upward trend. It has increased from 30,765.00 Cr. (Mar 2024) to 36,158.00 Cr., marking an increase of 5,393.00 Cr..

Notably, the Reserves (16,523.00 Cr.) exceed the Borrowings (6,402.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Jindal Stainless Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 22, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 21) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 22, the value is 82.33. This value is within the healthy range. It has increased from 29.40 (Mar 21) to 82.33, marking an increase of 52.93.
• For Diluted EPS (Rs.), as of Mar 22, the value is 82.33. This value is within the healthy range. It has increased from 29.40 (Mar 21) to 82.33, marking an increase of 52.93.
• For Cash EPS (Rs.), as of Mar 22, the value is 70.04. This value is within the healthy range. It has increased from 35.61 (Mar 21) to 70.04, marking an increase of 34.43.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 22, the value is 209.40. It has increased from 127.06 (Mar 21) to 209.40, marking an increase of 82.34.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 22, the value is 209.40. It has increased from 127.06 (Mar 21) to 209.40, marking an increase of 82.34.
• For Revenue From Operations / Share (Rs.), as of Mar 22, the value is 636.21. It has increased from 398.40 (Mar 21) to 636.21, marking an increase of 237.81.
• For PBDIT / Share (Rs.), as of Mar 22, the value is 96.31. This value is within the healthy range. It has increased from 52.31 (Mar 21) to 96.31, marking an increase of 44.00.
• For PBIT / Share (Rs.), as of Mar 22, the value is 85.71. This value is within the healthy range. It has increased from 40.00 (Mar 21) to 85.71, marking an increase of 45.71.
• For PBT / Share (Rs.), as of Mar 22, the value is 80.14. This value is within the healthy range. It has increased from 31.12 (Mar 21) to 80.14, marking an increase of 49.02.
• For Net Profit / Share (Rs.), as of Mar 22, the value is 59.45. This value is within the healthy range. It has increased from 23.30 (Mar 21) to 59.45, marking an increase of 36.15.
• For NP After MI And SOA / Share (Rs.), as of Mar 22, the value is 82.33. This value is within the healthy range. It has increased from 29.40 (Mar 21) to 82.33, marking an increase of 52.93.
• For PBDIT Margin (%), as of Mar 22, the value is 15.13. This value is within the healthy range. It has increased from 13.12 (Mar 21) to 15.13, marking an increase of 2.01.
• For PBIT Margin (%), as of Mar 22, the value is 13.47. This value is within the healthy range. It has increased from 10.04 (Mar 21) to 13.47, marking an increase of 3.43.
• For PBT Margin (%), as of Mar 22, the value is 12.59. This value is within the healthy range. It has increased from 7.81 (Mar 21) to 12.59, marking an increase of 4.78.
• For Net Profit Margin (%), as of Mar 22, the value is 9.34. This value is within the healthy range. It has increased from 5.84 (Mar 21) to 9.34, marking an increase of 3.50.
• For NP After MI And SOA Margin (%), as of Mar 22, the value is 12.94. This value is within the healthy range. It has increased from 7.38 (Mar 21) to 12.94, marking an increase of 5.56.
• For Return on Networth / Equity (%), as of Mar 22, the value is 39.56. This value is within the healthy range. It has increased from 23.34 (Mar 21) to 39.56, marking an increase of 16.22.
• For Return on Capital Employeed (%), as of Mar 22, the value is 32.67. This value is within the healthy range. It has increased from 21.92 (Mar 21) to 32.67, marking an increase of 10.75.
• For Return On Assets (%), as of Mar 22, the value is 19.66. This value is within the healthy range. It has increased from 9.84 (Mar 21) to 19.66, marking an increase of 9.82.
• For Long Term Debt / Equity (X), as of Mar 22, the value is 0.24. This value is within the healthy range. It has decreased from 0.42 (Mar 21) to 0.24, marking a decrease of 0.18.
• For Total Debt / Equity (X), as of Mar 22, the value is 0.37. This value is within the healthy range. It has decreased from 0.48 (Mar 21) to 0.37, marking a decrease of 0.11.
• For Asset Turnover Ratio (%), as of Mar 22, the value is 1.80. It has increased from 1.33 (Mar 21) to 1.80, marking an increase of 0.47.
• For Current Ratio (X), as of Mar 22, the value is 1.72. This value is within the healthy range. It has increased from 1.09 (Mar 21) to 1.72, marking an increase of 0.63.
• For Quick Ratio (X), as of Mar 22, the value is 1.00. This value is within the healthy range. It has increased from 0.49 (Mar 21) to 1.00, marking an increase of 0.51.
• For Inventory Turnover Ratio (X), as of Mar 22, the value is 4.79. This value is within the healthy range. It has increased from 3.57 (Mar 21) to 4.79, marking an increase of 1.22.
• For Interest Coverage Ratio (X), as of Mar 22, the value is 17.31. This value is within the healthy range. It has increased from 4.92 (Mar 21) to 17.31, marking an increase of 12.39.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 22, the value is 11.69. This value is within the healthy range. It has increased from 3.03 (Mar 21) to 11.69, marking an increase of 8.66.
• For Enterprise Value (Cr.), as of Mar 22, the value is 10,950.71. It has increased from 4,410.95 (Mar 21) to 10,950.71, marking an increase of 6,539.76.
• For EV / Net Operating Revenue (X), as of Mar 22, the value is 0.72. This value is below the healthy minimum of 1. It has increased from 0.46 (Mar 21) to 0.72, marking an increase of 0.26.
• For EV / EBITDA (X), as of Mar 22, the value is 4.82. This value is below the healthy minimum of 5. It has increased from 3.57 (Mar 21) to 4.82, marking an increase of 1.25.
• For MarketCap / Net Operating Revenue (X), as of Mar 22, the value is 0.60. This value is below the healthy minimum of 1. It has increased from 0.31 (Mar 21) to 0.60, marking an increase of 0.29.
• For Price / BV (X), as of Mar 22, the value is 1.86. This value is within the healthy range. It has increased from 0.99 (Mar 21) to 1.86, marking an increase of 0.87.
• For Price / Net Operating Revenue (X), as of Mar 22, the value is 0.60. This value is below the healthy minimum of 1. It has increased from 0.31 (Mar 21) to 0.60, marking an increase of 0.29.
• For EarningsYield, as of Mar 22, the value is 0.21. This value is below the healthy minimum of 5. It has decreased from 0.23 (Mar 21) to 0.21, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness